Results: From 02/2022 to 7/2022, 188 subjects were recruited in the study including 126 patients with heart failure with reduced ejection fraction; male 78.6%, female 21.4%; mean age 59, 3 ± 16, 4 and a control group consisted of 62 healthy subjects.